Answers are grounded in this paper and cite their sources.
Our massively parallel sequencing targeted DSD gene panel represents an economical means of improving the genetic diagnostic capability for patients affected by DSD. Implementation of this panel in a large cohort of patients has expanded our understanding of the underlying genetic etiology of DSD. The inclusion of research candidate genes also provides an invaluable resource for future identification of novel genes.
No takes yet. Share an insight, caveat, or question.
Eggers et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: